More tools:Markets·Screener·Research·Chat

Bristol-Myers Squibb Co. (BMY) Financial Statements

Bristol-Myers Squibb Co.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S8N8J6
XNYS · usd
66.12▼ 0.70 (-1.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close66.82
Day's Range66.58 – 67.72
52-Week Range42.52 – 68.64
Volume4.6M
Avg Volume10.3M
Share Statistics
Shares Outstanding
Employees32.5K
ExchangeXNYS
Listed1952-06-23
Share count as of July 22, 2026
Loading Income Statement…
Key questions about Bristol-Myers Squibb Co. (BMY)
What is Bristol-Myers Squibb Co.'s Market Cap?
Bristol-Myers Squibb Co.'s Market Cap is $135.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Enterprise Value?
Bristol-Myers Squibb Co.'s Enterprise Value is $170.2B, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Trailing P/E?
Bristol-Myers Squibb Co.'s Trailing P/E is 14.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Price / Sales?
Bristol-Myers Squibb Co.'s Price / Sales is 2.7×, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s EV / Revenue?
Bristol-Myers Squibb Co.'s EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s EV / EBITDA?
Bristol-Myers Squibb Co.'s EV / EBITDA is 10.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Revenue (TTM)?
Bristol-Myers Squibb Co.'s Revenue (TTM) is $49.2B, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Net Income (TTM)?
Bristol-Myers Squibb Co.'s Net Income (TTM) is $9.3B, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s EBITDA?
Bristol-Myers Squibb Co.'s EBITDA is $16.8B, based on as-reported figures from SEC (XBRL) filings.
What is Bristol-Myers Squibb Co.'s Diluted EPS (TTM)?
Bristol-Myers Squibb Co.'s Diluted EPS (TTM) is 4.54, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total Revenues
YoY growth+5.7%+2.6%+1.3%+2.8%
Cost of products sold
Selling, general and administrative
Research and development
Acquired IPRD
Amortization of acquired intangible assets
Other (income)/expense, net
Total Expenses
% of revenue68.5%71.8%88.2%74.5%
Earnings/(Loss) before income taxes
Income tax provision
Net earnings/(loss)
% of revenue25.6%23.3%8.7%18.0%
Noncontrolling interest
Net earnings/(loss) attributable to BMS
% of revenue25.6%23.3%8.7%18.0%
Earnings/(Loss) per common share:
Basic (usd per share)—
Diluted (usd per share)—